Uncertainties remain about the diagnostic and therapeutic strategy to prevent left ventricular thrombus formation after myocardial infarction. In particular, the roles of predisposing factors and prophylactic anticoagulation have not been sufficiently considered. We propose an ‘uncertainties flowchart’ with the aim of stimulating research on the topic.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Clinical profile and prognosis of elderly patients with left ventricular thrombus after anticoagulation
Thrombosis Journal Open Access 10 July 2023
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Habash, F. & Vallurupalli, S. Challenges in management of left ventricular thrombus. Ther. Adv. Cardiovasc. Dis. 11, 203–213 (2017).
Gellen, B. et al. Timing of cardiac magnetic resonance imaging impacts on the detection rate of left ventricular thrombus after myocardial infarction. JACC Cardiovasc. Imaging 10, 1404–1405 (2017).
Roifman, I., Connelly, K. A., Wright, G. A. & Wijeysundera, H. C. Echocardiography vs. cardiac magnetic resonance imaging for the diagnosis of left ventricular thrombus: a systematic review. Can. J. Cardiol. 31, 785–791 (2015).
Weinsaft, J. W. et al. Echocardiographic algorithm for post-myocardial infarction LV thrombus: a gatekeeper for thrombus evaluation by delayed enhancement CMR. JACC Cardiovasc. Imaging 9, 505–515 (2016).
McCarthy, C. P. et al. Left ventricular thrombus after acute myocardial infarction: screening, prevention, and treatment. JAMA Cardiol. 3, 642–649 (2018).
Massussi, M., Scotti, A., Lip, G. Y. H. & Proietti, R. Left ventricular thrombosis: new perspectives on an old problem. Eur. Heart J. Cardiovasc. Pharmacother. https://doi.org/10.1093/ehjcvp/pvaa066 (2020).
Lattuca, B. et al. Antithrombotic therapy for patients with left ventricular mural thrombus. J. Am. Coll. Cardiol. 75, 1676–1685 (2020).
Fleddermann, A. M., Hayes, C. H., Magalski, A. & Main, M. L. Efficacy of direct acting oral anticoagulants in treatment of left ventricular thrombus. Am. J. Cardiol. 124, 367–372 (2019).
Robinson, A. A. et al. Off-label use of direct oral anticoagulants compared with warfarin for left ventricular thrombi. JAMA Cardiol. 5, 685–692 (2020).
Camilli, M. et al. Direct oral anticoagulants vs. vitamin K antagonists for the treatment of left ventricular thrombosis: a systematic review of the literature and meta-analysis. Eur. Heart J. Cardiovasc. Pharmacother. https://doi.org/10.1093/ehjcvp/pvaa134 (2020).
Acknowledgements
L.A.F.D.O. thanks his mentors, L. Cacciavillani (University of Padova, Italy) and M. L. Lazzarotti (Ospedale di Vimercate, Italy).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Peer review information
Nature Reviews Cardiology thanks H. Thiele for their contribution to the peer review of this work.
Supplementary information
Rights and permissions
About this article
Cite this article
Di Odoardo, L.A.F., Stefanini, G.G. & Vicenzi, M. Uncertainties about left ventricular thrombus after STEMI. Nat Rev Cardiol 18, 381–382 (2021). https://doi.org/10.1038/s41569-021-00539-y
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41569-021-00539-y
This article is cited by
-
Clinical profile and prognosis of elderly patients with left ventricular thrombus after anticoagulation
Thrombosis Journal (2023)
-
Left Ventricular Thrombus Management After Acute Myocardial Infarction in Clinical Practice: Results from LEVITATION Survey and Narrative Review
Cardiovascular Drugs and Therapy (2022)
-
Rivaroxaban versus Vitamin K Antagonists (warfarin) based on the triple therapy for left ventricular thrombus after ST-Elevation myocardial infarction
Heart and Vessels (2022)